Seer (SEER) Shares Repurchased (2020 - 2024)
Seer (SEER) recorded quarterly Shares Repurchased of -$3.7 million in Q3 2024, down 28923.08% quarter-over-quarter from $13000.0 in Q3 2023, and down 28923.08% on a YoY basis from N/an in Q4 2023.
Seer (SEER) Shares Repurchased (2020 - 2024) Analysis & Trends
Seer's Shares Repurchased history runs 5 years deep, the most recent figure standing at -$3.7 million for Q3 2024.
- In Q3 2024, Shares Repurchased fell 28923.08% year-over-year to -$3.7 million; the TTM figure through Dec 2024 stood at -$3.7 million (down 28823.08% YoY), while the FY2023 annual figure was $13000.0, down 35.0% from the prior year.
- Shares Repurchased was -$3.7 million for Q3 2024 at Seer, down from $13000.0 in the prior quarter.
- In the past five years, Shares Repurchased ranged from a high of $22000.0 in Q3 2021 to a low of -$3.7 million in Q3 2024.
- Historically, Shares Repurchased has averaged -$366600.0 across 5 years, with a median of $7000.0 in 2020.
- The sharpest annual moves came in 2021 and 2024: Shares Repurchased soared 2300.0% in 2021, then sank 28923.08% in 2024.
- A 5-year view of Shares Repurchased shows it stood at $7000.0 in 2020, then jumped by 214.29% to $22000.0 in 2021, then sank by 104.55% to -$1000.0 in 2022, then soared by 1400.0% to $13000.0 in 2023, then tumbled by 28923.08% to -$3.7 million in 2024.
- The last three Shares Repurchased figures came in at -$3.7 million (Q3 2024), $13000.0 (Q3 2023), and -$1000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 839,896.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 336.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3.75 Mn |
| Sep 30, 2024 | -3.75 Mn |
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 7,000.00 |